<DOC>
	<DOCNO>NCT02714049</DOCNO>
	<brief_summary>Unblinded study flibanserin 8 week responder randomize 1:1 receive study medication alone vs. study medication sex therapy 12 additional week .</brief_summary>
	<brief_title>Flibanserin ( Addyi® ) vs. Flibanserin Sex Therapy</brief_title>
	<detailed_description>This unblinded study conduct single research center , San Diego Sexual Medicine . Subjects meet inclusion exclusion criterion receive flibanserin 8-week run-in period differentiate responder non-responders . Responders determine score 1-3 Patient Global Impression Improvement ( PGI-I ) 8 week baseline , randomize 1:1 receive study medication alone vs. study medication sex therapy additional 12 week .</detailed_description>
	<mesh_term>Hypokinesia</mesh_term>
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<criteria>1 . Subject willing able provide write informed consent HIPAA authorization study procedure conduct ; 2 . Subject female ; 3 . Subject ≥18 year old ; 4 . Subject biologicbased HSDD primary sexual complaint ; 5 . Subject score &lt; 26 FSFI &lt; 4.8 desire domain FSFI screening ; 6 . Subject score &gt; 18 FSDSDAO ; 7 . Subject answer yes question 14 DSDS screener ; 8 . Subject willing use effective contraception study premenopausal ( oral contraceptive , barrier method , long act reversible contraceptive , surgical sterilization ) ; 9 . Subject agree comply study procedures visit . 1 . Subject sexual pain ; 2 . Subject generalize , acquire HSDD ; 3 . Subject use flibanserin last 6 month ; 4 . Subject history alcohol drug abuse ; 5 . Subject use tobacco form ; 6 . Subject currently use androgen therapy unwilling washout ; 7 . Subject pregnant , nursing , plan become pregnant next 6 month ; 8 . Subject take moderate strong cytochrome P450 3A4 ( CYP3A4 ) inhibitor ; 9 . Subject take CYP3A4 inducer ; 10 . Pglycoprotein substrate ; 11 . Subject history liver impairment ; 12 . Subject chronic medical condition psychologic disorder Principal Investigator feel make ineligible study ; 13 . Subject condition exhibit behavior indicate Principal Investigator Subject unlikely compliant study procedures visit .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hypoactive sexual desire disorder</keyword>
	<keyword>Addyi</keyword>
	<keyword>flibanserin</keyword>
	<keyword>low sexual desire</keyword>
	<keyword>HSDD</keyword>
</DOC>